ANNUAL REPORT 2017
EXPLORE OUR PERSPECTIVES

NOTE 22. RESEARCH AND DEVELOPMENT

Research and development consists of the following:

 Year ended December 31,
 20162017
Research and development expenses101,536114,093
Capitalization of development expenses(26,484)(38,615)
Amortization of capitalized development expenses13,34513,288
Research and development grants and credits(843)(326)
Total research and development expenses87,55488,440
Impairment of research and development related assets3,5754,337
Total91,12992,777

The impairment expenses in 2016 and 2017 related to customer specific projects.

The Company’s operations in the Netherlands, Belgium and the United States receive research and development grants and credits from various sources.